dwaldman
True Blue
Below in the Medicare Physician Proposed Rule for 2017, it appears there are going to be new epidural codes to differ from with image guidance (Fluoroscopy, CT) or without image guidance
Revisions to Payment Policies under the Physician Fee Schedule and Other Revisions to Part B for CY 2017
https://s3.amazonaws.com/public-inspection.federalregister.gov/2016-16097.pdf
Page 384
623X5 Injection(s), of diagnostic or therapeutic substance(s) (eg, anesthetic, antispasmodic,
opioid, steroid, other solution), not including neurolytic substances, including needle or
catheter placement, interlaminar epidural or subarachnoid, cervical or thoracic; without
imaging guidance
623X6 Injection(s), of diagnostic or therapeutic substance(s) (eg, anesthetic, antispasmodic,
opioid, steroid, other solution), not including neurolytic substances, including needle or
catheter placement, interlaminar epidural or subarachnoid, cervical or thoracic; with imaging
guidance (ie, fluoroscopy or CT)
623X7 Injection(s), of diagnostic or therapeutic substance(s) (eg, anesthetic, antispasmodic,
opioid, steroid, other solution), not including neurolytic substances, including needle or
catheter placement, interlaminar epidural or subarachnoid, lumbar or sacral (caudal); without
imaging guidance
623X8 Injection(s), of diagnostic or therapeutic substance(s) (eg, anesthetic, antispasmodic,
opioid, steroid, other solution), not including neurolytic substances, including needle or
catheter placement, interlaminar epidural or subarachnoid, lumbar or sacral (caudal); with
imaging guidance (ie, fluoroscopy or CT)
623X9 Injection(s), including indwelling catheter placement, continuous infusion or intermittent
bolus, of diagnostic or therapeutic substance(s) (eg, anesthetic, antispasmodic, opioid, steroid,
other solution), not including neurolytic substances, interlaminar epidural or
subarachnoid, cervical or thoracic; without imaging guidance
62X10 Injection(s), including indwelling catheter placement, continuous infusion or intermittent
bolus, of diagnostic or therapeutic substance(s) (eg, anesthetic, antispasmodic, opioid, steroid,
other solution), not including neurolytic substances, interlaminar epidural or
subarachnoid, cervical or thoracic; with imaging
guidance (ie, fluoroscopy or CT)
62X11 Injection(s), including indwelling catheter placement, continuous infusion or intermittent
bolus, of diagnostic or therapeutic substance(s) (eg, anesthetic, antispasmodic, opioid, steroid,
other solution), not including neurolytic substances, interlaminar epidural or
subarachnoid, lumbar or sacral (caudal); without
imaging guidance
62X12 Injection(s), including indwelling catheter placement, continuous infusion or intermittent
bolus, of diagnostic or therapeutic substance(s) (eg, anesthetic, antispasmodic, opioid, steroid,
other solution), not including neurolytic substances, interlaminar epidural or
subarachnoid, lumbar or sacral (caudal); with imaging guidance (ie, fluoroscopy or CT)
Revisions to Payment Policies under the Physician Fee Schedule and Other Revisions to Part B for CY 2017
https://s3.amazonaws.com/public-inspection.federalregister.gov/2016-16097.pdf
Page 384
623X5 Injection(s), of diagnostic or therapeutic substance(s) (eg, anesthetic, antispasmodic,
opioid, steroid, other solution), not including neurolytic substances, including needle or
catheter placement, interlaminar epidural or subarachnoid, cervical or thoracic; without
imaging guidance
623X6 Injection(s), of diagnostic or therapeutic substance(s) (eg, anesthetic, antispasmodic,
opioid, steroid, other solution), not including neurolytic substances, including needle or
catheter placement, interlaminar epidural or subarachnoid, cervical or thoracic; with imaging
guidance (ie, fluoroscopy or CT)
623X7 Injection(s), of diagnostic or therapeutic substance(s) (eg, anesthetic, antispasmodic,
opioid, steroid, other solution), not including neurolytic substances, including needle or
catheter placement, interlaminar epidural or subarachnoid, lumbar or sacral (caudal); without
imaging guidance
623X8 Injection(s), of diagnostic or therapeutic substance(s) (eg, anesthetic, antispasmodic,
opioid, steroid, other solution), not including neurolytic substances, including needle or
catheter placement, interlaminar epidural or subarachnoid, lumbar or sacral (caudal); with
imaging guidance (ie, fluoroscopy or CT)
623X9 Injection(s), including indwelling catheter placement, continuous infusion or intermittent
bolus, of diagnostic or therapeutic substance(s) (eg, anesthetic, antispasmodic, opioid, steroid,
other solution), not including neurolytic substances, interlaminar epidural or
subarachnoid, cervical or thoracic; without imaging guidance
62X10 Injection(s), including indwelling catheter placement, continuous infusion or intermittent
bolus, of diagnostic or therapeutic substance(s) (eg, anesthetic, antispasmodic, opioid, steroid,
other solution), not including neurolytic substances, interlaminar epidural or
subarachnoid, cervical or thoracic; with imaging
guidance (ie, fluoroscopy or CT)
62X11 Injection(s), including indwelling catheter placement, continuous infusion or intermittent
bolus, of diagnostic or therapeutic substance(s) (eg, anesthetic, antispasmodic, opioid, steroid,
other solution), not including neurolytic substances, interlaminar epidural or
subarachnoid, lumbar or sacral (caudal); without
imaging guidance
62X12 Injection(s), including indwelling catheter placement, continuous infusion or intermittent
bolus, of diagnostic or therapeutic substance(s) (eg, anesthetic, antispasmodic, opioid, steroid,
other solution), not including neurolytic substances, interlaminar epidural or
subarachnoid, lumbar or sacral (caudal); with imaging guidance (ie, fluoroscopy or CT)